ISSN: 0973-7510

E-ISSN: 2581-690X

Research Article | Open Access
Mayada Noori Iqbal1, Sura O. Yosif2, Jasim Mohammed Muhsin1 and Jaleel Samanje1
1College of Health and Medical Techniques, Middle Technical University (MTU), Baghdad, Iraq.
2Institute of Medical Technology, Al-Mansour Middle Technical University (MTU), Baghdad, Iraq.
J Pure Appl Microbiol. 2022;16(2):1245-1251 | Article Number: 7411 | © The Author(s). 2022
Received: 05/11/2021 | Accepted: 06/04/2022 | Published online: 01/06/2022
Issue online: June 2022

The precise relationship between interleukins-33 and IL-5, as well as some trace elements and asthma, is unknown. The target of research was to compare and link the above-mentioned serological parameters in asthmatic patients and healthy controls. In 69 asthmatic patients and 35 healthy controls, serum levels of IL-33, IL-5, zinc, copper, iron, total IgE, Forced expiratory volume (FEV) and Forced expiratory volume (FEV) were compared. Spirometry was used to assess the (FEV) and (FVC) in asthmatic patients, as well as their age and body mass index (BMI). When asthmatic patients were matched to controls, mean levels of IL-33, IL-5, and total IgE appeared highly significant difference (p < 0.001). There was a substantial decline in zinc levels in the asthmatic group, but no significant drop in Copper levels. There was also a statistically significant difference in high Iron mean levels among asthmatic patients. In addition, the findings revealed a significant positive correlation between Iron and IgE levels in patients and the levels of (IL-33 and IL-5), plus a significant negative correlation with Zinc levels. Only Copper had no relationship with the interleukins studied. IL-33, also known as IL-5, is a novel inflammatory marker implicated in asthma progression by interacting with IgE, Zinc, Iron, but not Copper levels. As a result, it could be a one-of-a-kind therapeutic target in these patients.


Asthma, Copper, IL-5, IL-33, Iron, Zinc

Article Metrics

Article View: 39

Share This Article

© The Author(s) 2022. Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License which permits unrestricted use, sharing, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.